Evidence map›Paper›PMID 42330662›Full record

ReviewCurrent opinion in microbiology2026

Mutations in RNA polymerase that drive the emergence of antibiotic resistance.

Yesha Patel, John D Helmann

Abstract readReview
In one paragraph

Review in Current opinion in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yesha PatelDepartment of Microbiology, Cornell University, Ithaca, NY 14853-8101, USA.
John D HelmannDepartment of Microbiology, Cornell University, Ithaca, NY 14853-8101, USA. Electronic address: jdh9@cornell.edu.

Funding

Bacillus subtilis Stress ResponsesR35GM122461 · NIGMS · CORNELL UNIVERSITY · PI John D Helmann · 2017 to 2026
$7.6M
NIGMS NIH HHS R35 GM122461
6 · The paper itself

Abstract

RNA polymerase (RNAP) catalyzes transcription, the first step of gene expression. In bacteria, numerous regulatory proteins and signaling molecules fine-tune RNAP activity in a promoter-specific manner. The resultant changes in gene expression allow cells to acclimate to an ever-changing environment. In addition to phenotypic adaptation, increases in cell fitness can also result from changes in the genome. Here, we explore how mutations in RNAP structural genes benefit cells under diverse selection pressures, with a focus on antibiotics. Selection for resistance to rifampicin (RIF), an antibiotic that binds near the catalytic center of RNAP, leads almost exclusively to amino acid substitutions in the large β subunit that modify the RIF binding site. RIF

Indexed as

Anti-Bacterial AgentsBacteriaDNA-Directed RNA PolymerasesDrug Resistance, BacterialMutationBacterial ProteinsGene Expression Regulation, BacterialPromoter Regions, GeneticRifampinTranscription, GeneticAnti-Bacterial AgentsBacterial ProteinsDNA-Directed RNA PolymerasesRifampin

Identifiers

PMID42330662
PMCPMC13288759

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.